Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 22, 2020
Reply to: Exercise for "Sleep Rehabilitation" in Parkinson's Disease
Amy W Amara, Kimberly H Wood, Allen Joop, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 25, 2020
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease
Amy W Amara, Kimberly H Wood, Allen Joop, et al.
Therapeutic Advances in Neurological Disorders
|
April 24, 2026
Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
Moaz Elsayed Abouelmagd, Abdallah Abbas, Obai Yousef, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 10, 2016
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease
Roberto A Ortega, Paola A Torres, Matthew Swan, et al.
Drugs & Aging
|
October 19, 2023
Low-Income Older Adults' Vulnerability to Anticholinergic Medication-Associated Frailty
Lana Sargent, Kristin M Zimmerman, Almutairi Mohammed, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
December 16, 2024
The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies
Kathryn A Wyman-Chick, Matthew J Barrett, Michael J Miller, et al.
CNS Neuroscience & Therapeutics
|
August 4, 2024
Determining the role of statins in Parkinson's disease risk reduction and disease modification: A comprehensive meta-analysis of 4 million participants' data
Abdelrahman Mady, Yehia Nabil, Asma Daoud, et al.
Systematic Reviews
|
November 4, 2025
Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials
Moaz Elsayed Abouelmagd, Nereen A Almosilhy, Hamdy A Makhlouf, et al.
Annals of Clinical and Translational Neurology
|
April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Daniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Neurology and Therapy
|
May 8, 2024
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians
Kathryn A Wyman-Chick, Parichita Chaudhury, Ece Bayram, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 22, 2020
Reply to: Exercise for "Sleep Rehabilitation" in Parkinson's Disease
Amy W Amara, Kimberly H Wood, Allen Joop, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 25, 2020
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease
Amy W Amara, Kimberly H Wood, Allen Joop, et al.
Therapeutic Advances in Neurological Disorders
|
April 24, 2026
Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
Moaz Elsayed Abouelmagd, Abdallah Abbas, Obai Yousef, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
February 10, 2016
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease
Roberto A Ortega, Paola A Torres, Matthew Swan, et al.
Drugs & Aging
|
October 19, 2023
Low-Income Older Adults' Vulnerability to Anticholinergic Medication-Associated Frailty
Lana Sargent, Kristin M Zimmerman, Almutairi Mohammed, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
December 16, 2024
The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies
Kathryn A Wyman-Chick, Matthew J Barrett, Michael J Miller, et al.
CNS Neuroscience & Therapeutics
|
August 4, 2024
Determining the role of statins in Parkinson's disease risk reduction and disease modification: A comprehensive meta-analysis of 4 million participants' data
Abdelrahman Mady, Yehia Nabil, Asma Daoud, et al.
Systematic Reviews
|
November 4, 2025
Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials
Moaz Elsayed Abouelmagd, Nereen A Almosilhy, Hamdy A Makhlouf, et al.
Annals of Clinical and Translational Neurology
|
April 15, 2020
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Daniel Weintraub, Chelsea Caspell-Garcia, Tanya Simuni, et al.
Neurology and Therapy
|
May 8, 2024
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians
Kathryn A Wyman-Chick, Parichita Chaudhury, Ece Bayram, et al.
Page
of 8